K120300 is an FDA 510(k) clearance for the CT-GUIDE NEEDLE GUIDANCE SYSTEM. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.
Submitted by Activiews, Ltd. (Washington, US). The FDA issued a Cleared decision on April 13, 2012 after a review of 73 days - a notably fast clearance cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
NCT01367392
Completed
Interventional
Industry-sponsored
Effectiveness and Safety of CT-guided Needle Placement in the Liver With the Aid of the ActiSight Needle Guidance System
Confirmation of Clinical Effectiveness and Safety of CT-guided Needle Placement in the Liver With the Aid of the ActiSight Needle Guidance System
| Condition studied |
Accurate Navigation to the Lesion |
| Study design |
Single group |
| Eligibility |
All sexes
· 18 Years+
|
| Sponsor |
ActiViews Ltd.
(industry)
|
Started 2011-06-01
→
Primary completion 2012-01-01
Study completed - no results published.
This trial concluded in 2012 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
View full study on ClinicalTrials.gov